Keech C, Miller VE, Rizzardi B, Hoyle C, et al. Immunogenicity and safety of BPZE1, an intranasal live attenuated pertussis vaccine, versus tetanus-diphtheria-acellular pertussis vaccine: a randomised, double-blind, phase 2b trial. Lancet 2023;401:843-855.
PMID: 36906345